Invivyd, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Loss
(UNaudited)
(In thousands, except share and per share amounts)
| Three Months Ended March 31, | Three Months Ended March 31, | |
|---|---|---|
| 2026 | 2025 | |
| Revenue: | ||
| Product revenue, net | $13,744 | $11,304 |
| Total revenue | 13,744 | 11,304 |
| Operating costs and expenses: | ||
| Cost of product revenue(1) | 1,032 | 834 |
| Research and development(2) | 30,731 | 10,641 |
| Selling, general and administrative | 25,117 | 16,751 |
| Total operating costs and expenses | 56,880 | 28,226 |
| Loss from operations | (43,136) | (16,922) |
| Other income: | ||
| Other income, net | 1,736 | 633 |
| Total other income, net | 1,736 | 633 |
| Net loss | (41,400) | (16,289) |
| Other comprehensive income (loss) | ||
| Unrealized gain (loss), net of tax | 4 | (8) |
| Comprehensive loss | $(41,396) | $(16,297) |
| Net loss per share attributable to common stockholders, basic and diluted | $(0.13) | $(0.14) |
| Weighted-average common shares outstanding, basic and diluted | 309,670,101 | 119,883,479 |
(1)
Includes related-party amounts of$550 and $452 for the three months ended March 31, 2026 and 2025, respectively (see Note 15).
(2)
Includes related-party amounts of$1,127 and $1,128 for thethree months ended March 31, 2026 and 2025, respectively(see Note 15).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.